欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/H/0803/003
药品名称Octreotide LAI Teva CR
活性成分
    • octreotide acetate 30.0 mg
剂型Powder and solvent for suspension for injection
上市许可持有人Teva Pharmaceuticals CR s.r.o. Radlická 3185/1c, Prague 15000 Czech Republic
参考成员国 - 产品名称Czechia (CZ)
Octreotide LAI Teva CR
互认成员国 - 产品名称
    许可日期2019/04/16
    最近更新日期2023/03/17
    药物ATC编码
      • H01CB02 octreotide
    申请类型
    • TypeLevel1:Known Active Substance
    • TypeLevel2:Initial Application
    • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
    • TypeLevel4:Chemical Substance
    • TypeLevel5:Prescription Only
    附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase